WYLUMRI

Serial Number 98752470
730

Registration Progress

Application Filed
Sep 16, 2024
Under Examination
Mar 18, 2025
Approved for Publication
Jan 21, 2025
Published for Opposition
Jan 21, 2025
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Mar 18, 2026 136 days

Trademark Image

WYLUMRI

Basic Information

Serial Number
98752470
Filing Date
September 16, 2024
Published for Opposition
January 21, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Sep 9, 2025
Application
Pending
Classes
005 016 044

Rights Holder

Incyte Holdings Corporation

03
Address
1801 Augustine Cut-Off
Wilmington, DE 19803

Ownership History

Incyte Holdings Corporation

Original Applicant
03
Wilmington, DE

Incyte Holdings Corporation

Owner at Publication
03
Wilmington, DE

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

Next Deadline
136 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
March 18, 2026
Extension Available
Until March 18, 2026

Application History

13 events
Date Code Type Description Documents
Sep 10, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 9, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 9, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 9, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 18, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 21, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 21, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 15, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 25, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 23, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 16, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Sep 16, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 16, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of fibrotic disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD)
Class 016
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building
Class 044
Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, fibrotic, skeletal, chondrocyte and dermatological disorders

Classification

International Classes
005 016 044